Actively Recruiting

All Genders
NCT06692868

Fertility Protection for Children, Adolescents and Young Adults

Led by University of Ulm · Updated on 2025-01-16

2000

Participants Needed

1

Research Sites

1038 weeks

Total Duration

On this page

Sponsors

U

University of Ulm

Lead Sponsor

G

German Federal Ministry of Education and Research

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study focuses on improving fertility preservation and long-term care for children, adolescents, and young adults (CAYA) undergoing cancer treatments or stem cell transplantation. These treatments can harm fertility, and ensuring that patients receive the right support and follow-up care is critical. The main study goals are: 1. Understanding Fertility Risks: Researchers aim to identify factors that predict fertility problems after cancer treatments, such as the type of therapy, hormone levels, body composition, or genetic predispositions. 2. Addressing Patient and Family Needs: The program will explore the concerns, needs, and challenges faced by young patients and their parents regarding fertility. It will also examine how these issues affect their quality of life. 3. Improving Clinical Care: Current practices in fertility preservation and counseling will be studied to identify gaps and improve care structures. To achieve these goals, the program will: * Create a database to collect and analyze medical data from patients before, during, and after cancer treatments. * Study the prevalence and long-term effects of fertility problems in young patients. * Document medical interventions like fertility preservation methods (e.g., freezing eggs or sperm) and treatments for late effects. * Assess patients' and families' fertility-related quality of life and their informational needs. Ultimately, the project aims to establish an interdisciplinary center to support fertility preservation and improve the quality of care for young patients facing cancer and its treatments.

CONDITIONS

Official Title

Fertility Protection for Children, Adolescents and Young Adults

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children, adolescents, or young adults diagnosed with cancer before the age of 21 years
  • Children, adolescents, or young adults undergoing stem cell transplantation for malignant or non-malignant conditions before the age of 21 years
  • Treated at the Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Sektion Pädiatrische Endokrinologie und Diabetologie

Ulm, Baden-Wurttemberg, Germany, 89075

Actively Recruiting

Loading map...

Research Team

C

Christian Denzer, Prof. Dr.

CONTACT

M

Martin Wabitsch, Prof. Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here